NRX Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
The page contains a zero-cost Sustainability report covering NRX Pharmaceuticals Inc. If you work at NRX Pharmaceuticals Inc and you wish to licence your ESG rating, please get in touch. The assessment of NRX Pharmaceuticals Inc is assembled by All Street Sevva using cutting edge Cognitive Robots.
NRX Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.6; made up of an environmental score of 4.0, social score of 4.8 and governance score of 8.0.
5.6
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
579 | Tonix Pharmaceuticals Holding Corp | 5.7 | High |
579 | VIVA Biotech Holdings | 5.7 | High |
602 | NRX Pharmaceuticals Inc | 5.6 | High |
602 | Celltrion Inc | 5.6 | High |
602 | Adaptimmune Therapeutics PLC | 5.6 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |
Frequently Asked Questions
Does NRX Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes NRX Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes NRX Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes NRX Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes NRX Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes NRX Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes NRX Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes NRX Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes NRX Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes NRX Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes NRX Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes NRX Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes NRX Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes NRX Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes NRX Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes NRX Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes NRX Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid NRX Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes NRX Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes NRX Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas NRX Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes NRX Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes NRX Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes NRX Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes NRX Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes NRX Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes NRX Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes NRX Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs NRX Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes NRX Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes NRX Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes NRX Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes NRX Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes NRX Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes NRX Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes NRX Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for NRX Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware.